Literature DB >> 1837145

Identification of the discontinuous binding site in human interleukin 1 beta for the type I interleukin 1 receptor.

E Labriola-Tompkins1, C Chandran, K L Kaffka, D Biondi, B J Graves, M Hatada, V S Madison, J Karas, P L Kilian, G Ju.   

Abstract

Human interleukin 1 beta (IL-1 beta) exerts its diverse biological effects by binding to specific receptors on target cells. Two types of IL-1 receptor (IL-1R) have been identified: the type I IL-1R (p80) and the type II IL-1R (p68). Using site-specific mutagenesis, we have identified the binding site on IL-1 beta for the murine type I IL-1R. Analogs of the IL-1 beta protein containing defined amino acid substitutions were produced and tested for competitive binding to the two IL-1Rs. Substitutions of the amino acids at seven positions resulted in analogs that had greater than or equal to 100-fold reductions in competitive binding to the type I IL-1R, while maintaining substantial binding to the type II IL-1R. These seven amino acids (Arg-4, Leu-6, Phe-46, Ile-56, Lys-93, Lys-103, and Glu-105) are clustered in the IL-1 beta molecule, forming a discontinuous binding site. The side chains of all seven residues are exposed on the surface of IL-1 beta. The cumulative binding energies contributed by each of the residues predict a binding affinity that is consistent with the observed Kd of the wild-type protein for the type I IL-1R.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1837145      PMCID: PMC53098          DOI: 10.1073/pnas.88.24.11182

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Construction of interleukin-1 alpha mutants using unequal contamination of synthetic oligonucleotides.

Authors:  K Poindexter; R Jerzy; R B Gayle
Journal:  Nucleic Acids Res       Date:  1991-04-25       Impact factor: 16.971

2.  Site directed mutants of human interleukin-1 alpha: a 1H-NMR and receptor binding study.

Authors:  A M Gronenborn; P T Wingfield; H R McDonald; U Schmeissner; G M Clore
Journal:  FEBS Lett       Date:  1988-04-11       Impact factor: 4.124

3.  cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily.

Authors:  J E Sims; C J March; D Cosman; M B Widmer; H R MacDonald; C J McMahan; C E Grubin; J M Wignall; J L Jackson; S M Call
Journal:  Science       Date:  1988-07-29       Impact factor: 47.728

4.  A mutant protein of human interleukin-1 beta with immunostimulatory but not pyrogenic potency.

Authors:  S Nakai; K Kawai; Y Hirai; K Tasaka
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

5.  Crystallization of purified recombinant human interleukin-1 beta.

Authors:  D B Carter; K A Curry; C S Tomich; A W Yem; M R Deibel; D E Tracey; J W Paslay; J B Carter; N Y Theriault; P K Harris
Journal:  Proteins       Date:  1988

6.  Conversion of the interleukin 1 receptor antagonist into an agonist by site-specific mutagenesis.

Authors:  G Ju; E Labriola-Tompkins; C A Campen; W R Benjamin; J Karas; J Plocinski; D Biondi; K L Kaffka; P L Kilian; S P Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

7.  Point mutations of human interleukin-1 with decreased receptor binding affinity.

Authors:  H R MacDonald; P Wingfield; U Schmeissner; A Shaw; G M Clore; A M Gronenborn
Journal:  FEBS Lett       Date:  1986-12-15       Impact factor: 4.124

8.  The cell surface receptors for interleukin-1 alpha and interleukin-1 beta are identical.

Authors:  S K Dower; S R Kronheim; T P Hopp; M Cantrell; M Deeley; S Gillis; C S Henney; D L Urdal
Journal:  Nature       Date:  1986 Nov 20-26       Impact factor: 49.962

9.  Interleukin 1 alpha and interleukin 1 beta bind to the same receptor on T cells.

Authors:  P L Kilian; K L Kaffka; A S Stern; D Woehle; W R Benjamin; T M Dechiara; U Gubler; J J Farrar; S B Mizel; P T Lomedico
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

10.  Identification of a common class of high affinity receptors for both types of porcine interleukin-1 on connective tissue cells.

Authors:  T A Bird; J Saklatvala
Journal:  Nature       Date:  1986 Nov 20-26       Impact factor: 49.962

View more
  8 in total

1.  High affinity type I interleukin 1 receptor antagonists discovered by screening recombinant peptide libraries.

Authors:  S D Yanofsky; D N Baldwin; J H Butler; F R Holden; J W Jacobs; P Balasubramanian; J P Chinn; S E Cwirla; E Peters-Bhatt; E A Whitehorn; E H Tate; A Akeson; T L Bowlin; W J Dower; R W Barrett
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

Review 2.  Structural biology of the IL-1 superfamily: key cytokines in the regulation of immune and inflammatory responses.

Authors:  Brian Krumm; Yan Xiang; Junpeng Deng
Journal:  Protein Sci       Date:  2014-03-04       Impact factor: 6.725

3.  Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist.

Authors:  J A Symons; P R Young; G W Duff
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

Review 4.  Inflammasome regulation in driving COVID-19 severity in humans and immune tolerance in bats.

Authors:  Sahana Nagaraja; Disha Jain; Sannula Kesavardhana
Journal:  J Leukoc Biol       Date:  2021-05-31       Impact factor: 6.011

5.  Characterisation and expression analysis of the Atlantic halibut (Hippoglossus hippoglossus L.) cytokines: IL-1β, IL-6, IL-11, IL-12β and IFNγ.

Authors:  Aina-Cathrine Øvergård; Ina Nepstad; Audun Helge Nerland; Sonal Patel
Journal:  Mol Biol Rep       Date:  2011-06-05       Impact factor: 2.316

6.  Structure and function of chicken interleukin-1 beta mutants: uncoupling of receptor binding and in vivo biological activity.

Authors:  Wen-Ting Chen; Wen-Yang Huang; Ting Chen; Emmanuel Oluwatobi Salawu; Dongli Wang; Yi-Zong Lee; Yuan-Yu Chang; Lee-Wei Yang; Shih-Che Sue; Xinquan Wang; Hsien-Sheng Yin
Journal:  Sci Rep       Date:  2016-06-09       Impact factor: 4.379

7.  Conversion of human interleukin-4 into a high affinity antagonist by a single amino acid replacement.

Authors:  N Kruse; H P Tony; W Sebald
Journal:  EMBO J       Date:  1992-09       Impact factor: 11.598

8.  Structural differences between the putative carbohydrate-recognition domains of human IL-1 alpha, IL-1 beta and IL-1 receptor antagonist obtained by in silico modeling.

Authors:  Gérard Vergoten; Jean-Pierre Zanetta
Journal:  Glycoconj J       Date:  2007-03-06       Impact factor: 3.009

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.